A V Antelava Selected Research

richlocaine

9/2003

Effect of richlocaine alone or in combination with energostim on the severity of endotoxemia and survival of the skin under conditions of reduced blood flow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A V Antelava Research Topics

Disease

2	Endotoxemia 03/2004 - 09/2003
1	Non-alcoholic Fatty Liver Disease 07/2012
1	Abdominal Obesity 07/2012
1	Osteoporosis 07/2009
1	Bone Resorption 07/2009
1	Infections 06/2007
1	Thyrotoxicosis 03/2006
1	Myocarditis (Carditis) 03/2004
1	Heart Failure 03/2004
1	Necrosis 09/2003
1	Ischemia 09/2003
1	Infarction (Infarctions) 09/2003
1	Coronary Occlusion 09/2003

Drug/Important Bio-Agent (IBA)

3	energostimIBA 03/2004 - 09/2003
1	Insulin (Novolin)FDA Link 07/2012
1	Estrogens (Estrogen)FDA Link 07/2012
1	FluoridesIBA 07/2009
1	Parathyroid Hormone (Parathormone)IBA 07/2009
1	Estrogen ReceptorsIBA 07/2009
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2009
1	Diphosphonates (Bisphosphonates)IBA 07/2009
1	Teriparatide (Parathar)FDA Link 07/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2007
1	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2004
1	Superoxide DismutaseIBA 09/2003
1	Oxygen (Dioxygen)IBA 09/2003
1	NAD (NADH)IBA 09/2003
1	richlocaineIBA 09/2003
1	Cytochromes c (Cytochrome c)IBA 09/2003
1	Glutathione PeroxidaseIBA 09/2003
1	AntioxidantsIBA 09/2003
1	Local AnestheticsIBA 09/2003

Therapy/Procedure

2	Therapeutics 03/2004 - 09/2003
1	Secondary Prevention 07/2009
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 07/2009
1	Drug Therapy (Chemotherapy) 07/2009
1	Injections 03/2006